SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Phibro Animal Health Corp. – ‘DEFA14A’ on 9/16/22

On:  Friday, 9/16/22, at 4:40pm ET   ·   Accession #:  1104659-22-100866   ·   File #:  1-36410

Previous ‘DEFA14A’:  ‘DEFA14A’ on 9/17/21   ·   Next & Latest:  ‘DEFA14A’ on 9/15/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/16/22  Phibro Animal Health Corp.        DEFA14A                1:43K                                    Toppan Merrill/FA

Additional Definitive Proxy Soliciting Material   —   Schedule 14A   —   Rule 14a-12

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEFA14A     Additional Definitive Proxy Soliciting Material     HTML     21K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.         )

 

 

 

Filed by the Registrant x
Filed by a Party other than the Registrant ¨

Check the appropriate box:
¨ Preliminary Proxy Statement
¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨ Definitive Proxy Statement
x Definitive Additional Materials
¨ Soliciting Material under §240.14a-12

 

 

 

Phibro Animal Health Corporation
(Name of Registrant as Specified In Its Charter)

 

 

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

 

 

Payment of Filing Fee (Check the appropriate box):
x No fee required.
¨ Fee paid previously with preliminary materials.
¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 C: 

 

 

Phibro Animal Health Corporation

Glenpointe Centre East, 3rd Floor

300 Frank W. Burr Blvd., Ste 21

Teaneck, NJ 07666

 

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting To be held on Monday, November 7, 2022

 

Dear Stockholder:

 

You are receiving this notice to inform you that the proxy materials for our 2022 Annual Meeting of Stockholders are available on the internet. In accordance with rules adopted by the U.S. Securities and Exchange Commission, we are using the internet as our primary means of furnishing proxy materials to our stockholders. This communication presents only an overview of the more complete proxy materials that are available to you on the internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

The proxy statement and annual report to stockholders are available at: http://www.astproxyportal.com/ast/18918/. If you want to receive a paper or e-mail copy of these documents, you must request one by sending an e-mail to investor.relations@pahc.com or by calling +1 (201) 329-7334. You will have the opportunity to make a request to receive paper copies for all future meetings or only for the 2022 Annual Meeting of Stockholders. There is no charge to you for requesting a copy. Please make your request for a copy on or before October 24, 2022 to facilitate timely delivery. We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

The 2022 Annual Meeting of Stockholders (the Annual Meeting) of Phibro Animal Health Corporation (the Company) will be held at 9:00 A.M. Eastern Time on Monday, November 7, 2022, at the Company s offices located at Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck NJ 07666. Only holders who owned shares of the Company s Class A common stock and Class B common stock as of the close of business on September 9, 2022 (the Record Date), may vote at the Annual Meeting or any adjournment or postponement of the Annual Meeting that may take place.

 

Proposals to be voted on at the Annual Meeting are listed below along with the Board of Directors recommendations:

 

the election of the following two Class III Directors to serve until the 2025 annual meeting of stockholders and until their successors are duly elected and qualified:

 

Jack C. Bendheim; and

E. Thomas Corcoran

 

The Board of Directors recommends that you vote FOR this proposal.

 

a proposal to approve, on an advisory basis, the compensation of our named executive officers. The Board of Directors recommends that you vote FOR this proposal.

 

a proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company s independent registered public accounting firm for the Company s fiscal year ending June 30, 2023. The Board of Directors recommends that you vote FOR this proposal.

 

 C: 

 

You may access the following proxy materials at http://www.astproxyportal.com/ast/18918/:

 

Notice of the 2022 Annual Meeting of Stockholders;
 The Company s 2022 Proxy Statement;
The Company s Annual Report on Form 10-K for the Fiscal Year Ended June 30, 2022; and
The Proxy Card.

 

If you are a stockholder of record, there are two ways to vote:

 

 by completing and mailing your proxy card; or
 by written ballot at the Annual Meeting.

 

Stockholders of record as of the Record Date are encouraged and cordially invited to attend the 2022 Annual Meeting of Stockholders. Stockholders may request directions to the Company’s offices in order to attend the Annual Meeting by calling +1 (201) 329-7334.

 

  By order of the Board of Directors,
   
  /s/ Thomas G. Dagger
  Thomas G. Dagger
  Senior Vice President, General Counsel and Corporate Secretary
  September 16, 2022

 

 C: 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘DEFA14A’ Filing    Date    Other Filings
6/30/23
11/7/22DEF 14A
10/24/22
Filed on:9/16/22DEF 14A
9/9/22
6/30/2210-K
 List all Filings 
Top
Filing Submission 0001104659-22-100866   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 16, 12:09:47.1am ET